Oversight of the comprehensive clinical cancer screening and survivorship program development, strategic planning, and community outreach.The survivorship program is a multidisciplinary program including comprehensive annual surveillance, cancer screening, nutrition, physical therapy and integrative modalities, This program was graded highly by the Commission of Cancer and is currently expanding throughout the Roswell Care Network. Specialty program in men and women's sexual health… Show more Oversight of the comprehensive clinical cancer screening and survivorship program development, strategic planning, and community outreach.The survivorship program is a multidisciplinary program including comprehensive annual surveillance, cancer screening, nutrition, physical therapy and integrative modalities, This program was graded highly by the Commission of Cancer and is currently expanding throughout the Roswell Care Network. Specialty program in men and women's sexual health, acupuncture, and restorative dermatology. The Cancer Screening program at Roswell includes access to breast, colon, lung cancer screening and prostate exams. In addition, there are specialty programs in pancreatic cancer screening, comprehensive clinical genetics, and community based navigation to colorectal screening for high risk populations. Show less

Research interests focus on the early detection and chemoprevention of lung cancer, surveillance, screening and mapping the precancer atlas genome and transcriptome of lung cancer, including the evaluation of genetic/epigenetic biomarkers of early lesions in high risk populations. She is actively developing lung cancer chemoprevention/interception projects with agents targeting inflammation and vaccines targeting the EGF/EGFR pathways and the evaluation of genetic/epigenetic biomarkers of early… Show more Research interests focus on the early detection and chemoprevention of lung cancer, surveillance, screening and mapping the precancer atlas genome and transcriptome of lung cancer, including the evaluation of genetic/epigenetic biomarkers of early lesions in high risk populations. She is actively developing lung cancer chemoprevention/interception projects with agents targeting inflammation and vaccines targeting the EGF/EGFR pathways and the evaluation of genetic/epigenetic biomarkers of early lesions in high risk populations. Overseeing the High Risk Lung Cancer Screening Clinic at Roswell Park, where high risk patients are screened with low-dose CT, protocol driven interventional bronchoscopy, with recruitment into clinical trials related to biomarker, and chemoprevention. Show less